St. Gallen 2007: Breast cancer treatment consensus report

被引：31

作者：

Harbeck, Nadia

Jakesz, Raimund

机构：

[1] Tech Univ Munich, Frauenklin, D-81675 Munich, Germany

[2] Med Univ Vienna, Klin Abt Allgemeine, Vienna, Austria

来源：

BREAST CARE | 2007年 / 2卷 / 03期

关键词：

breast cancer; endocrine treatment; chemotherapy; antibody therapy; targeted therapy; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; TAMOXIFEN; METAANALYSIS; TRASTUZUMAB; ANASTROZOLE; THERAPY; TRIAL;

D O I：

10.1159/000103629

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The focus of this year's St. Gallen Consensus Conference was on providing substantial and largely evidence-based recommendations for the treatment of early breast cancer, indicating a broad spectrum of acceptable clinical practice. This report summarises the results of the 2007 international panel voting procedures with regard to endocrine treatment, chemotherapy and antibody therapy.

引用

页码：130 / 134

页数：5

共 16 条

[1]

AGO, DIAGN TREATM PAT PRI

[2]

Cuzick J, 2007, LANCET, V369, P1711

[3]

CUZICK J, 2006, 29 ANT BREAST CANC S

[4]

DAVIDSON N, 10 INT GALL C 2007

[5] Concordance among gene-expression-based predictors for breast cancer [J].

Fan, Cheng ;

Oh, Daniel S. ;

Wessels, Lodewyk ;

Weigelt, Britta ;

Nuyten, Dimitry S. A. ;

Nobel, Andrew B. ;

van't Veer, Laura J. ;

Perou, Charles M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) :560-569

[6] First-select the target:: better choice of adjuvant treatments for breast cancer patients [J].

Goldhirsch, A. ;

Coates, A. S. ;

Gelber, R. D. ;

Glick, J. H. ;

Thuerlimann, B. ;

Senn, H. -J. .

ANNALS OF ONCOLOGY, 2006, 17 (12) :1772-1776

[7] Meeting highlights:: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [J].

Goldhirsch, A ;

Glick, JH ;

Gelber, RD ;

Coates, AS ;

Thürlimann, B ;

Senn, H ;

Albain, KS ;

Bergh, J ;

Castiglione-Gertsch, M ;

Coates, AS ;

Costa, A ;

Cuzick, J ;

Davidson, N ;

Forbes, JF ;

Gelber, RD ;

Goss, P ;

Harris, J ;

Glick, JH ;

Goldhirsch, A ;

Howell, A ;

Ingle, JN ;

Jakesz, R ;

Jassem, J ;

Kaufmann, M ;

Martin, M ;

Mauriac, L ;

Morrow, M ;

Mouridsen, HT ;

Namer, M ;

Piccart-Gebhart, MJ ;

Possinger, K ;

Pritchard, K ;

Rutgers, EJT ;

Thürlimann, B ;

Viale, G ;

Wallgren, A ;

Wood, WC .

ANNALS OF ONCOLOGY, 2005, 16 (10) :1569-1583

[8]

GOSS P, 2007, 10 INT GALL C 2007

[9] Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17 [J].

Goss, PE ;

Ingle, JN ;

Martino, S ;

Robert, NJ ;

Muss, HB ;

Piccart, MJ ;

Castiglione, M ;

Tu, DS ;

Shepherd, LE ;

Pritchard, KI ;

Livingston, RB ;

Davidson, NE ;

Norton, L ;

Perez, EA ;

Abrams, JS ;

Cameron, DA ;

Palmer, MJ ;

Pater, JL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) :1262-1271

[10] Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial [J].

Jakesz, R ;

Jonat, W ;

Gnant, M ;

Mittlboeck, M ;

Greil, R ;

Tausch, C ;

Hilfrich, J ;

Kwasny, W ;

Menzel, C ;

Samonigg, H ;

Seifert, M ;

Gademann, G ;

Kaufmann, M .

LANCET, 2005, 366 (9484) :455-462

← 1 2 →